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Abstract. Female DBA/2 mice inoculated with 1 x 106 L 1210 leukemia cells died,
more rapidly than simultaneously inoculated male mice with a mean survival of 0.1 ±
0.2 days vs. 7.2 =•=0.4 days. For males, this represents an average of 18% longer
survival than females. Trials involving gonadectomy or treatment with exo-
genous sex hormones suggest that the sex difference in mortality was due to exacer-
bation of L 1210 leukemia by estrogen.
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This report describes the effect of sex,
gonadectomy and sex hormone treatment
on mortality of DBA/2 mice carrying
L 1210 transplantable murine leukemia.
L 1210 is widely used as a screening en-
tity in leukemia (Schabel et al 1966;
Hofer and Hofer 1971). Recognition of
a sex difference in the mortality pattern
may be of value in improving the reli-
ability of the test. A sex difference in
susceptibility and resistance has been
seen in a number of other diseases, in-
cluding cancer (Gobe and Konopka 1973;
Weiss et al 1973; Yohn 1973; Yohn et al
1967; Metcalf 1971).
METHODS AND MATERIALS
L 1210 Leukemia. L 1210 cells were main-
tained in DBA/2 mice using a 7 day transfer
cycle. Mean weight of mice at time of use was
23.9=*= 1.2 g. One ml of ascites fluid was drawn
from a donor mouse, diluted, and the white
cells counted. The cell count was adjusted, if
necessary, with sterile Lockes solution so that
0.1 ml contained approximately 1 x 106 cells.
For experimental procedures, 0.1 ml of the ad-justed solution was injected intraperitoneally.
Sham inoculated animals (controls) were in-jected intraperitoneally with 0.1 ml of sterile
Lockes solution. There were no deaths in any
sham group. The mean survival time of the
several groups of DBA/2 mice inoculated with
1 x 106 cells in this study varied between 6.1
and 7.2 days with an overall mean of 6.6=^0.3
days, in agreement with the known dynamics of
L 1210 leukemia (Skipper et al 1964).
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Sex Differences. Three procedures were used
to explore the sex differences. The first simply
involved simultaneously inoculating male and
female DBA/2 mice with 1 x 106 L 1210 cells
and observing the mortality patterns. Four
such trials were conducted. In the second pro-
cedure, male and female mice were gonadecto-
mized several weeks before L 1210 inoculation.
Mice were anesthetized with sodium pento-
barbital (about 27 Mg/g mouse). For orchi-
dectomy, the scrotum and tunica were cut and
the testes expelled with slight abdominal pres-
sure. Blood vessels were ligated before the
testes were cut free and separate sutures were
used to close the tunica and the scrotum. A
topical antibiotic (nitrofurazone) was sprinkled
on the wound. For ovariectomy, bilateral in-
cisions 0.5 cm long were made 0.5 cm on each
side of the spine, extending posteriorly from the
last rib. The ovaries were exteriorized, isolated
by ligature and cut free. Separate sutures were
used to close muscle and skin, and the anti-
biotic was sprinkled on the wound. Approxi-
mately 2 weeks recovery was allowed prior to
L 1210 inoculation.
The third procedure involved treatment with
hormones one day before L 1210 inoculation.
Males were given 125 /zg Delestrogen (estradiol
valerate) in peanut oil, subcutaneously. Fe-
males were injected with 4 mg Delatestryl
(testosterone enanthate) in peanut oil, sub-
cutaneously. The dose for long acting hor-
mones was derived from Drug Dose in Lab-
oratory Animals (Barns and Eltherington 1964).
Controls received peanut oil alone before the
L 1210 cells. Two gonadectomy and 2 hormone
treatment trials were carried out.
RESULTS
The cumulative percent mortality plot
shows that female DBA/2 mice died sig-
nificantly more rapidly than the males
following inoculation with L 1210 cells
(fig. 1). While mortality appeared simi-
lar on day 5, some 70% of the females,
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as compared to 35% of the males, were
dead by day 6. The female mean sur-
vival was 6.1 ±0.2 (SE) days while the
male mean survival was 7.2 ±0.4 days
(table 1). This difference was significant
at the p<0.01 level using a t-test. Us-
ing a probit plot of the pooled data, the
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FIGURE 1. Sex difference in survival of
DBA/2 mice following inoculation with
1 x 106 L 1210 leukemia cells. (Avg. of 4
trials, involving a total of 36 male and 42
female mice.)
male LT50 was estimated as day 6.7 post-
inoculation and the female LT50 as day
5.5. This difference was also significantly
different (p<0.01) using a Chi Square
Test. While males lived only 1.1 to 1.2
days longer than females, on the average,
this amounts to an 18% increase in sur-
vival time.
After gonadectomy, the sex difference
in mortality was absent (table 1). The
mean survival time for both gonadecto-
mized males and females was 7.0 days
and the LT50 was 6.5 days, similar to
normal males. After treatment with
exogenous hormones of the opposite sex,
the sex difference in mortality was again
absent (table 1). In this case, however,
the mean survival of 6.2 days and the
LT50 of 5.5 days were similar to those of
normal females. Peanut oil alone did
not alter the mortality pattern.
DISCUSSION
These results suggest that the more
rapid mortality in female DBA/2 mice
inoculated with L 1210 leukemia cells
was due to an estrogenic effect. With
hormones lacking due to gonadectomy,
both males and females responded as
normal males. Thus, gonadectomized
females survived longer, but gonadec-
tomy did not affect mortality in the
males. In the procedure where mice
were treated with hormones of the op-
posite sex, both sexes responded as nor-
mal females. Thus, estrogen treated
males died sooner than normal males, but
androgen did not affect the mortality pat-
tern in the females. Estrogen thus ap-
peared to exacerbate (to some extent) the
TABLE 1
Effect of sex and sex hormone treatment on survival of DBA/2 mice inoculated with
106 L 1210 leukemia cells.
Treatment No. of Total number Mean Survival LT5
trials of mice (days=±=SE)
MALES
L 1210 only 4
Gonadectomy+L 1210 2
Estrogen+L 1210** 2
FEMALES
L 1210 only 4
Gonadectomy+L 1210 2
Androgen+L 1210f 2
36
8
10
43
8
10
7.2±0.4H
7.0±0.4
6.2±0.2
6.1±0.2
7.0±0.4
6.2±0.3
5.5
5.5
6.5
5.5
•Significantly different from similarly treated females (p<0.01).
**Intraperitoneal injection of 125 ng Delestrogen (estradiol valerate), in peanut oil, S.C.
flntraperitoneal injection of 5 mg Delatestryl (testosterone enanthate), in peanut oil, S.C.
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L1210 leukemia disease process while
androgens had little effect.
Estrogen has been implicated in other
experimental cancers. Females are more
susceptible to avian adenovirus, due to
estrogenic enhancement of adenovirus
oncogenesis (Jones et al 1970) and female
hamsters develop tumors more readily,
have a shorter survival time and show
regression less often than male hamsters
(Yohn 1973; Yohn et al 1967; Hatch et al
1970). In cell cultures, female hamster
cells were transformed with adenovirus
with a higher frequency than male cells,
a result which was enhanced by the addi-
tion of estrogen (Fong and Ledinko 1970;
Milo et al 1972). Enhancement of dis-
ease process in the female however, is far
from universal. In infectious diseases
caused by pneumococcus, the female was
shown to be more resistant than the male
(Weiss et al 1973). The sex difference in
susceptibility to tumors induced with
benzo(a)pyrene was shown to depend on
the tissue involved (Vesselinovitch et al
1975) and in leukemias involving AKR,
RF and C58 mice, a sex difference exists
but which sex is more susceptible de-
pends upon the specific type of leukemia
(Metcalf 1971).
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